Website Survey

Our teams

Meet our Leadership Team and Board of Directors

Leadership Team

Ramji Srinivasan

Ramji Srinivasan

Co-Founder & Chief Executive Officer

As CEO, Ramji oversees operations and technological development at Counsyl. He’s played an integral role in the creation of Counsyl’s highly-automated lab, as well as the company’s platform for patient and doctor communications. Before Counsyl, Ramji was a financial associate at Morgan Stanley. Ramji earned a B.S. in computer science and an M.S. in financial mathematics, both from Stanford University.

Eric Evans

Eric Evans

Co-Founder & Chief Science Officer

Dr. Eric Evans has been with Counsyl since its inception. He joined the founding team to blend his scientific research and knowledge with real-world patient and doctor experiences. Eric is an expert in next-generation sequencing, molecular diagnostics, and molecular genetics. His research has been published in scientific journals including Aging Cell, Reproductive Biology & Endocrinology, PLoS Pathogens, and Genetics in Medicine. At Counsyl he oversees the clinical laboratory, research and development. Eric is a certified High-Complexity Laboratory Director and Clinical Genetic Molecular Biologist Scientist. Eric holds a Ph.D. in genetics from Stanford University. He was the recipient of a National Science Foundation Research Fellowship as well as a Stanford Graduate Fellowship.

Rishi Kacker

Rishi Kacker

Co-Founder & VP, Products

Rishi’s focus is bringing together software with the human touch to make genetic screening a routine part of clinical care. His expertise is taking traditionally complex systems and making them simple, scalable and accessible. Prior to Counsyl, he cofounded Voltage Security, a cryptography and data security startup which was acquired by HP Enterprise (NYSE: HPE). As the head of Counsyl’s engineering and product development teams, he has built a platform for modern diagnostic lab services including on-demand genetic counseling, automated results delivery, clinical interpretation, medical billing and lab information management. Rishi holds a B.S. in computer science from Stanford University.

Ted Snelgrove

Ted Snelgrove

Chief Business Officer

With more than 25 years of commercial, product management and team leadership experience, Ted is responsible for driving product management and commercial strategies for Counsyl. Ted has deep experience in the molecular diagnostic sector, having built and led the original commercial team at Genomic Health. He later helped build Crescendo Bioscience and served as CEO at CellScape. Most recently, Ted was the Oncology/Hematology Business Unit Head at Jazz Pharmaceuticals. He got his start in the industry at Eli Lilly and progressed through commercial and strategy roles at Immunex, Amgen and ALZA. He received an MBA in Marketing from the University of Michigan and previously served as an officer in the US Navy.

Dr. James Goldberg

Dr. James Goldberg

Chief Medical Officer

Dr. Goldberg leads Counsyl’s collaboration with the medical community, executes high-impact clinical studies, and helps educate patients and physicians on screening benefits. He is board-certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics, and is a founding fellow of the American College of Medical Genetics. He was previously the director of the Reproductive Genetics Unit at the University of California, San Francisco and subsequently co-director of the Prenatal Diagnosis Center at California Pacific Medical Center and partner at San Francisco Perinatal Associates. Dr. Goldberg has also served as president of the Perinatal Quality Foundation and on the board of the Society for Maternal Fetal Medicine. He has published extensively in the area of prenatal diagnosis and has served on committees that establish national policy in obstetrical care.

Joel Jung

Joel Jung

Chief Financial Officer

Joel Jung joins Counsyl with nearly 20 years of experience as an executive in the life sciences industry. Most recently, Joel was the Chief Financial Officer of BioNano Genomics, a privately held company that is developing a new genomic mapping platform. Prior to BioNano, Joel was the Chief Financial Officer and Treasurer of AgraQuest, a privately held biotechnology company, where he played an integral role in the company’s acquisition by Bayer in 2012. Before AgraQuest, Joel was the Chief Financial Officer and Treasurer for the Celera Corporation where he led the financial team in the spinout from the Applera Corporation, listing the company as an independent, publicly traded company. Joel’s experience also includes working at Chiron Corporation for 11 years in several executive financial positions. He began his finance career at Bank of America. Joel earned an MBA from the University of California, Berkeley, Haas School of Business and a B.S. from Purdue University.

Matthew Meyer

Matthew Meyer

SVP, Corporate Development

Matt leads Counsyl’s business development, licensing, strategic planning and alliance management functions. With over 20 years’ experience at both large public and small private, VC-backed pharmaceutical and molecular diagnostic companies in the United States and Europe including Pfizer, Novartis and CareDx, Matt has been instrumental in driving growth through creative strategic international partnerships, development and commercialization collaborations, joint ventures, mergers and acquisitions and private and public financings. As a licensed lawyer, Matt also brings a strong understanding of the complex and dynamic regulatory, IP and reimbursement landscape to his role. Matt earned a B.A. cum laude from Cornell University and a J.D. from Villanova University.

John Tan

John Tan

SVP, Operations

John Tan is the Senior Vice President of Operations and is responsible for scaling and optimizing operations including quality, supply chain, IT and engineering. With more than 25 years of experience in managing global manufacturing operations, he most recently served as Vice President of Global Operations Engineering at Amazon. In that role, John was responsible for the engineering design and capital procurement of a multi-billion dollar group for Amazon’s worldwide fulfillment centers, fresh/pantry facilities and transportation logistics. Prior to Amazon, he served in senior operations roles at both Thermo Fisher and PerkinElmer, both in the U.S. and abroad.

Marilee Moy

Marilee Moy

VP, People

Marilee is a senior business leader with a track record of achieving business-focused HR results. Prior to joining Counsyl, Marilee held VP HR positions at Questcor, Nikon and Charles Schwab. She has extensive experience in health care companies such as Genentech, Abbott Laboratories and Johnson & Johnson and has also worked in startup tech environments. Marilee received her B.A. in Communications from Boston College and her MBA from Golden Gate University.

Peter Soparkar

Peter Soparkar

General Counsel

Peter Soparkar joins Counsyl from Jazz Pharmaceuticals, where he led the legal team’s operations support and delivered on numerous debt and equity financings and four landmark transactions, including the launched tender-offer of Celator, the acquisitions of Italy-based Gentium, UK based EUSA Pharma, and the acquisition of and inversion into Ireland based Azur Pharma. Prior to Jazz, Peter worked at Latham & Watkins in London and San Francisco, with a practice spanning international and domestic markets, as well as private and public transactions. His deep life-sciences legal experience includes support for development activities, corporate governance, legal and regulatory compliance, public companies and compliant commercial activities. He received a J.D. from New York University and a B.A. from Oberlin College.

Board of Directors

John DeLoche

John DeLoche

John DeLoche is a Co-Founder and Managing Director of Pilot Growth Equity, a growth equity firm with offices in San Francisco, New York and Washington, D.C. Mr. DeLoche has more than 20 years of experience in technology investing and technology-related finance. In addition to Counsyl, he serves on the boards of Metabiota and CB Insights and he has invested in many successful technology companies including Proofpoint (Nasdaq: PFPT) and Jasper (acquired by Cisco). Mr. DeLoche began his career as a founding member of Credit Suisse First Boston’s Technology Group, where he executed technology mergers, acquisitions and financings and worked in the firm’s New York, Tokyo and Palo Alto offices. Mr. DeLoche has advised technology entrepreneurs and leading global technology companies on over 100 M&A and financing transactions totaling more than $25 billion. Mr. DeLoche served as an officer in the US Army Reserve Signal Corps, which develops, tests and manages communications and information systems for the combined armed forces. Mr. DeLoche holds an AB with honors from the University of Chicago.

Eric Evans

Eric Evans

Co-Founder & Chief Science Officer

Dr. Eric Evans has been with Counsyl since its inception. He joined the founding team to blend his scientific research and knowledge with real-world patient and doctor experiences. Eric is an expert in next-generation sequencing, molecular diagnostics, and molecular genetics. His research has been published in scientific journals including Aging Cell, Reproductive Biology & Endocrinology, PLoS Pathogens, and Genetics in Medicine. At Counsyl he oversees the clinical laboratory, research and development. Eric is a certified High-Complexity Laboratory Director and Clinical Genetic Molecular Biologist Scientist. Eric holds a Ph.D. in genetics from Stanford University. He was the recipient of a National Science Foundation Research Fellowship as well as a Stanford Graduate Fellowship.

Matthew Fust

Matthew Fust

Mr. Fust joined Counsyl as a board member in 2014. He is an advisor to life sciences companies, executive teams and investors. From 2009 through 2013, he was Executive Vice President and Chief Financial Officer of Onyx Pharmaceuticals, culminating in the company’s sale to Amgen. He previously served as Senior Vice President and Chief Financial Officer of Jazz Pharmaceuticals (2003 – 2008), Chief Financial Officer of Perlegen Sciences (2002 – 2003), and Senior Vice President and Chief Financial Officer of ALZA Corporation, where he was an executive from 1996 through the company’s acquisition by Johnson & Johnson in 2001. Prior to joining ALZA, Matthew was a member of the healthcare strategy consulting practice at Andersen Consulting (now Accenture). Mr. Fust serves on the boards of directors of Atara Biotherapeutics, Dermira, MacroGenics, Sunesis Pharmaceuticals and Ultragenyx Pharmaceutical. He holds an undergraduate degree from the University of Minnesota and an M.B.A. from the Stanford University Graduate School of Business.

Jack Goldstein, PhD

Jack Goldstein, PhD

Dr. Goldstein joined Counsyl as a board member in 2016. Jack Goldstein’s most recent operating role was as President and COO of Chiron Corporation, which had approximately $2B in revenues with a market cap of $9.5B and included biopharmaceuticals, vaccines, and transfusion diagnostics. Chiron was acquired by Novartis in a multi-billion dollar transaction in 2006. Prior to this, Jack was CEO of Applied Imaging and held several executive management positions at J&J, including President of Ortho Diagnostic Systems. He has served on the boards of Illumina, Orasure, and Immucor and is currently on the board of Accuray and Chairman of the Board of OncoGenex Pharmaceuticals.

Dr. Scott Hayworth

Dr. Scott Hayworth

Dr. Hayworth joined Counsyl as a board member in 2016. Dr. Scott Hayworth trained as an OB-GYN and is currently President and CEO of CareMount Medical, P.C. (formerly Mount Kisco Medical Group, P.C.). In his 18 years as President and CEO, Scott has transformed the medical group from 40 physicians and 3 locations to 550 physicians and 41 locations. He has served major leadership roles including Chairman of the American Medical Group Association (AMGA) and the National Executive Board of the American Congress of Obstetricians and Gynecologists (ACOG). He is currently on the board of a number of private equity-backed companies, a Senior Advisor at Arsenal Capital, and an Associate Dean at the Icahn School of Medicine at Mount Sinai.

Leo Joseph

Mr. Joseph joined Counsyl as a board member in 2014. Leo Joseph is a successful entrepreneur and private investor. He was a Cofounder and Chief Operating Officer at Sibyte (sold to Broadcom, $2B) and at P.A. Semi (sold to Apple). Present board memberships include Counsyl, Farm Hill, Imergy Power Systems, and Woven (observer). He also produces Independent movies. Leo has a M.S. in Operations Research from UMASS, Amherst and an MBA from Stanford University.

Rishi Kacker

Rishi Kacker

Co-Founder & VP, Products

Rishi’s focus is bringing together software with the human touch to make genetic screening a routine part of clinical care. His expertise is taking traditionally complex systems and making them simple, scalable and accessible. Prior to Counsyl, he cofounded Voltage Security, a cryptography and data security startup which was acquired by HP Enterprise (NYSE: HPE). As the head of Counsyl’s engineering and product development teams, he has built a platform for modern diagnostic lab services including on-demand genetic counseling, automated results delivery, clinical interpretation, medical billing and lab information management. Rishi holds a B.S. in computer science from Stanford University.

Ramji Srinivasan

Ramji Srinivasan

Co-Founder & Chief Executive Officer

As CEO, Ramji oversees operations and technological development at Counsyl. He’s played an integral role in the creation of Counsyl’s highly-automated lab, as well as the company’s platform for patient and doctor communications. Before Counsyl, Ramji was a financial associate at Morgan Stanley. Ramji earned a B.S. in computer science and an M.S. in financial mathematics, both from Stanford University.